Trials / Not Yet Recruiting
Not Yet RecruitingNCT05799469
Study of Chemoradiotherapy With Envafolimab For The Treatment of Locally Advanced Cervical Cancer
A Single-arm Exploratory Clinical Study of Envafolimab With Chemoradiotherapy for Women With Locally Advanced Cervical Cancer
- Status
- Not Yet Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 36 (estimated)
- Sponsor
- Chongqing University Cancer Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This is a single-arm, single-center, exploratory study, the purpose of this study is to evaluate the efficacy and safety of envafolimab combined with Chemoradiotherapy in participants with locally advanced cervical cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Envafolimab | SC |
| DRUG | Cisplatin | IV infusion |
| RADIATION | External Beam Radiotherapy (EBRT) | 45-50.4Gy |
| RADIATION | Brachytherapy (BT) | Performed according to clinically required dose |
Timeline
- Start date
- 2023-05-01
- Primary completion
- 2027-05-31
- Completion
- 2027-12-31
- First posted
- 2023-04-05
- Last updated
- 2023-04-05
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05799469. Inclusion in this directory is not an endorsement.